1/20
09:00 am
idxg
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
High
Report
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
12/3
01:22 pm
idxg
Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners [Yahoo! Finance]
Medium
Report
Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners [Yahoo! Finance]
12/3
12:12 pm
idxg
Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners
Medium
Report
Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners
11/13
01:09 am
idxg
Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M [Seeking Alpha]
Low
Report
Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M [Seeking Alpha]
11/12
04:27 pm
idxg
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results [Yahoo! Finance]
Low
Report
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results [Yahoo! Finance]
11/12
04:01 pm
idxg
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results
Low
Report
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results